Search

6 results for “glycemic control”

• Research ArticleOpen Access

  Use of Fixed-dose Combination Therapy with Remogliflozin and Vildagliptin as an Add-on Drug in Improving the Glycemic Control of Type 2 Diabetes Mellitus: An Observational Study

  Velammal Petchiappan, Elsa Mathew, Josna Jose, Mohamed Fardan, Yoganathan Chidambaram, Saravanan Thangavelu

  Vol. 14 · Issue 1 · pp. 72–78

  https://doi.org/10.1177/0976500X231175219
  Full text ↗PDF

• Research PaperOpen Access

  Is the peripheral arterial disease in low risk type 2 diabetic patients influenced by body mass index, lipidemic control, and statins?

  Jayesh Dalpatbhai Solanki, Amit H. Makwana, Hemant B. Mehta, Pradnya A. Gokhale, Chinmay J. Shah

  Vol. 7 · Issue 2 · pp. 87–92

  https://doi.org/10.4103/0976-500X.184772
  Full text ↗PDF

• Mini ReviewOpen Access

  Statin induced diabetes and its clinical implications

  Umme Aiman, Ahmad Najmi, Rahat Ali Khan

  Vol. 5 · Issue 3 · pp. 181–185

  https://doi.org/10.4103/0976-500X.136097
  Full text ↗PDF

• Research ArticleOpen Access

  Predictors of Pharmacotherapy and Quality of Life Among Patients With Diabetic Foot Syndrome: A Cross-Sectional Study from a Tertiary Care Hospital in India

  E. Pasangha, B. George, K. B. Bhuvana, D. Padmini

  Vol. 13 · Issue 1 · pp. 66–71

  https://doi.org/10.1177/0976500X221080291
  Full text ↗PDF

• Case ReportOpen Access

  Insulin glargine overdose

  Fatma Sarı Doğan, Özge Ecmel Onur, Arzu Denizbaşı Altınok, Özlem Güneysel

  Vol. 3 · Issue 4 · pp. 333–335

  https://doi.org/10.4103/0976-500X.103694
  Full text ↗PDF

• Educational ForumOpen Access

  Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus

  Darshan J. Dave

  Vol. 2 · Issue 4 · pp. 230–235

  https://doi.org/10.4103/0976-500X.85934
  Full text ↗PDF